GR3019791T3 - Pharmaceutical composition for inhibiting platelet aggregation - Google Patents

Pharmaceutical composition for inhibiting platelet aggregation

Info

Publication number
GR3019791T3
GR3019791T3 GR960401171T GR960401171T GR3019791T3 GR 3019791 T3 GR3019791 T3 GR 3019791T3 GR 960401171 T GR960401171 T GR 960401171T GR 960401171 T GR960401171 T GR 960401171T GR 3019791 T3 GR3019791 T3 GR 3019791T3
Authority
GR
Greece
Prior art keywords
pharmaceutical composition
platelet aggregation
inhibiting platelet
alkyl group
lower alkyl
Prior art date
Application number
GR960401171T
Other languages
English (en)
Inventor
Akio Odawara
Yasuhiko Sasaki
Sakae Murata
Hiroshi Narita
Original Assignee
Tanabe Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tanabe Seiyaku Co filed Critical Tanabe Seiyaku Co
Publication of GR3019791T3 publication Critical patent/GR3019791T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
GR960401171T 1992-02-06 1996-04-29 Pharmaceutical composition for inhibiting platelet aggregation GR3019791T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP6790192 1992-02-06

Publications (1)

Publication Number Publication Date
GR3019791T3 true GR3019791T3 (en) 1996-07-31

Family

ID=13358264

Family Applications (1)

Application Number Title Priority Date Filing Date
GR960401171T GR3019791T3 (en) 1992-02-06 1996-04-29 Pharmaceutical composition for inhibiting platelet aggregation

Country Status (12)

Country Link
US (1) US5382577A (el)
EP (1) EP0555042B1 (el)
JP (1) JP2712144B2 (el)
KR (1) KR100187997B1 (el)
AT (1) ATE136216T1 (el)
CA (1) CA2087743C (el)
DE (1) DE69302035T2 (el)
DK (1) DK0555042T3 (el)
ES (1) ES2088224T3 (el)
GR (1) GR3019791T3 (el)
HK (1) HK1000122A1 (el)
TW (1) TW276997B (el)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5637582A (en) * 1992-10-23 1997-06-10 Tanabe Seiyaku Co., Ltd. Peripheral circulation improving agent
EP0595526B1 (en) * 1992-10-23 1997-09-10 Tanabe Seiyaku Co., Ltd. Peripheral circulation improving agent
GB9311948D0 (en) * 1993-06-10 1993-07-28 Zeneca Ltd Substituted nitrogen heterocycles
US5801168A (en) * 1994-06-09 1998-09-01 Zeneca Limited Substituted nitrogen heterocycles
US6043368A (en) * 1996-09-04 2000-03-28 Poli Industria Chimica, S.P.A. Method of making thieno-pyridine derivatives
US5872128A (en) * 1997-10-15 1999-02-16 Invamed, Inc. Stabilized composition of ticlopidine hydrochloride
KR100258018B1 (ko) * 1997-12-23 2000-07-01 유승필 티클로피딘과 은행잎 추출물을 함유한 약제조성물
WO1999065500A1 (en) * 1998-06-17 1999-12-23 Bristol-Myers Squibb Company Preventing cerebral infarction through administration of adp-receptor antiplatelet and antihypertensive drugs in combination
EP1350511B1 (en) 2000-12-25 2008-09-10 Daiichi Sankyo Company, Limited Medicinal compositions containing aspirin
US6706658B2 (en) * 2001-12-21 2004-03-16 Engelhard Corporation Catalyst for purification of aromatic acids

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3562257A (en) * 1967-10-28 1971-02-09 Tanabe Seiyaku Co Benzothiazepine derivatives
FR2215948B1 (el) * 1973-02-01 1976-05-14 Centre Etd Ind Pharma
FR2307538A1 (fr) * 1975-04-18 1976-11-12 Centre Etd Ind Pharma Nouveau medicament anti-agregant plaquettaire
US4567175A (en) * 1983-06-03 1986-01-28 Tanabe Seiyaku Co., Ltd. 8-Chloro-1,5-benzothiazepine derivatives
US4590188A (en) * 1984-02-18 1986-05-20 Tanabe Seiyaku Co., Ltd. 1,5-benzothiazepine derivatives and their pharmaceutical use
FR2589358B1 (fr) * 1985-07-30 1987-12-04 Synthelabo Compositions pharmaceutiques a base de diltiazem et d'aspirine
JP2520119B2 (ja) * 1986-03-18 1996-07-31 名古屋アイ・イ−・シ−株式会社 流体の集中配送装置
DE3626097A1 (de) * 1986-07-31 1988-02-11 Goedecke Ag Wirkstoffkombination enthaltend diltiazem und acetylsalicylsaeure
JPH0228594A (ja) * 1988-06-13 1990-01-30 Mitsubishi Nuclear Fuel Co Ltd 下部ノズルの取付装置
JPH078799B2 (ja) * 1990-09-17 1995-02-01 田辺製薬株式会社 血小板凝集抑制組成物
JPH078798B2 (ja) * 1990-09-17 1995-02-01 田辺製薬株式会社 血小板凝集抑制組成物

Also Published As

Publication number Publication date
CA2087743A1 (en) 1993-08-07
JPH05279257A (ja) 1993-10-26
ATE136216T1 (de) 1996-04-15
KR100187997B1 (ko) 1999-06-01
DK0555042T3 (da) 1996-08-19
CA2087743C (en) 1999-04-27
DE69302035D1 (de) 1996-05-09
HK1000122A1 (en) 1997-12-12
EP0555042B1 (en) 1996-04-03
JP2712144B2 (ja) 1998-02-10
EP0555042A1 (en) 1993-08-11
DE69302035T2 (de) 1996-08-29
TW276997B (el) 1996-06-01
KR930017581A (ko) 1993-09-20
ES2088224T3 (es) 1996-08-01
US5382577A (en) 1995-01-17

Similar Documents

Publication Publication Date Title
PH22136A (en) Dihydropyridazinone derivatives and use thereof
TW276997B (el)
PL309874A1 (en) Novel derivatives of pyrrolocarbasol, method of obtaining them and pharmaceutical composition containing such derivatives
FR2666741B1 (fr) Composition therapeutique pour inhiber l'agregation plaquettaire.
HUT63426A (en) Process for producing 5-(2-chlorobenzyl)-4,5,6,7-tetryhydro-thieno/3,2-c/pyridine and its salts
AU1947992A (en) Preparation of 2-(2-thienyl)ethylamine and synthesis of thieno(3,2-c) pyridine derivatives therefrom
IE901104L (en) New bronchospasmolytic compounds and process for their¹preparation
IE882142L (en) Naphthothiazepine derivatives and preparation thereof
TW207498B (el)
TW275629B (el)
HUP0004806A3 (en) Benzo[5,6]cyclohepta[1,2-b]pyridine derivatives useful for inhibition of farnesyl protein transferase and medicaments containing the compounds
IL113309A0 (en) Imidazopyridine derivatives, their preparation and use
ES8701144A1 (es) Un procedimiento para preparar un derivado de tetrahidronaf-taleno
TW273511B (el)
EP0845463A4 (en) THIAZOLINE DERIVATIVES